Long Noncoding RNAs as Drivers of Acquired Chemoresistance in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Long Noncoding RNAs as Drivers of Acquired Chemoresistance in Hepatocellular Carcinoma

Published:2020 Issue: Volume: Page:199-227
ISSN:2197-9731
Container-title:RNA Technologies
language:
Short-container-title:

Author:

DiStefano Johanna K.,Sukowati Caecilia

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-44743-4_8

Reference153 articles.

1. Abou-Alfa GK, Huitzil-Melendez FD, O’Reilly EM et al (2008) Current management of advanced hepatocellular carcinoma. Gastrointest Cancer Res 2:64–70

2. Abou-Alfa GK, Meyer T, Cheng AL et al (2018) Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med 379:54–63

3. Abudoureyimu M, Zhou H, Zhi Y et al (2019) Recent progress in the emerging role of exosome in hepatocellular carcinoma. Cell Prolif 52:e12541

4. Adriaens C, Standaert L, Barra J et al (2016) p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med 22:861–868

5. Akinyemiju T, Abera S, Ahmed M et al (2017) The burden of primary liver Cancer and underlying etiologies from 1990 to 2015 at the global, regional, and National Level: results from the global burden of disease study 2015. JAMA Oncol 3:1683–1691

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways;Pathology - Research and Practice;2024-08